Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
PatSnap Eureka Desktop
NEWAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
NEWProfessional Services
Law Firms
Life Sciences
High-Tech
Competitor Tech Research
Design Risk Screening
Telecom SEP Claim Chart
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report How IL-17A/F bispecific antibodies like bimekizumab are reshaping treatment of psoriasis, psoriatic arthritis, and hidradenitis suppurativa. Patent landscape analysis.
Article | Report How to implement OPC UA over TSN for deterministic real-time communication in smart factories — patent analysis covering CUC/CNC, gate scheduling, and PTP sync.
Article | Report Electroactive polymer actuator patent landscape 2026: key assignees, emerging clusters, and strategic IP implications across medical, haptics, and robotics.
Article | Report How to implement OPC UA over TSN in smart factories: protocol architecture, CUC/CNC configuration, gate scheduling, and timing sync — drawn from 40+ patents.
Article | Report Tezepelumab, itepekimab, and next-gen bispecific alarmin blockers are reshaping severe asthma biologics. Explore the patent landscape and pipeline signals.
Article | Report Explore the 2026 bispecific antibody manufacturing patent landscape: Fc engineering, continuous bioprocessing, Chinese biotech filings, and emerging format strategies.
Article | Report A deep analysis of bispecific antibody manufacturing patent landscape 2026: Fc engineering, continuous bioprocessing, Chinese biotech filings, and emerging format strategies.
Article | Report How next-generation anti-amyloid antibodies, bispecific platforms, and tau-targeting modalities are reshaping the Alzheimer's disease pipeline after lecanemab's approval.
Article | Report How psilocybin, 5-MeO-DMT, LSD and novel analogues are reshaping the patent landscape for treatment-resistant depression and PTSD. Deep-dive analysis.
Article | Report How foundation model fine-tuning transforms PCB automated optical inspection: patent intelligence covering hybrid pipelines, CLIP-based prompt learning, and continual learning.
Article | Report Mapping the 2026 autonomous robotic surgery patent landscape: AI navigation, collision avoidance, tendon-drive control, and the assignees shaping surgical autonomy.
Article | Report Small molecules, cyclic peptides, oral ASOs and combination strategies targeting PCSK9 in ASCVD — a patent-driven analysis of the next-generation pipeline.
Article | Report How foundation model fine-tuning transforms PCB automated optical inspection: patent intelligence across 40+ filings from Siemens, Bosch, Tsinghua & more.
Article | Report A 2026 patent landscape analysis of autonomous robotic surgery: AI navigation, collision avoidance, tendon-drive control, and the top assignees shaping the field.
Article | Report How milvexian and asundexian are reshaping stroke prevention by targeting Factor XIa — Phase II data, patent landscape, and pipeline strategy decoded.